Related Articles for PubMed (Select 16318637)

Ann Intern Med. 2007 Apr 3;146(7):477-85. Erratum in: Ann Intern Med. 2007 Jun 19;146(12):896. Summary for patients in: Ann Intern Med. 2007 Apr 3;146(7):I18.

PMID: 17404349 [PubMed - indexed for MEDLINE]

10:

Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial.

Suppapitiporn S, Chindavijak B, Onsanit S.

J Med Assoc Thai. 2005 Sep;88 Suppl 4:S134-41.

PMID: 16623018 [PubMed - indexed for MEDLINE]

11:

Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes.

Shi YF, Pan CY, Hill J, Gao Y.

Diabet Med. 2005 Dec;22(12):1737-43.

PMID: 16401321 [PubMed - indexed for MEDLINE]

12:

Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483.

PMID: 16861090 [PubMed - indexed for MEDLINE]

13:

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials.

Buse JB, Klonoff DC, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, Maggs DG, Wintle ME.

Clin Ther. 2007 Jan;29(1):139-53.

PMID: 17379054 [PubMed - indexed for MEDLINE]

14:

Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus.

Hollander P.

Am J Med. 2007 Feb;120(2 Suppl 1):S18-28; discussion S29-32.

PMID: 17296341 [PubMed - indexed for MEDLINE]

15:

The effect of pioglitazone on glycemic and lipid parameters and adverse events in elderly patients with type 2 diabetes mellitus: a post hoc analysis of four randomized trials.

Rajagopalan R, Xu Y, Abbadessa M; Quartet Study Group.

Am J Geriatr Pharmacother. 2006 Jun;4(2):123-33.

PMID: 16860259 [PubMed - indexed for MEDLINE]

16:

Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

Roberts VL, Stewart J, Issa M, Lake B, Melis R.

Clin Ther. 2005 Oct;27(10):1535-47.

PMID: 16330290 [PubMed - indexed for MEDLINE]

17:

Impact of Web-based nurse's education on glycosylated haemoglobin in type 2 diabetic patients.

Hee-Sung K.

J Clin Nurs. 2007 Jul;16(7):1361-6.

PMID: 17584355 [PubMed - indexed for MEDLINE]

18:

Insulin therapy, glycemic control, and cardiovascular risk factors in young Latin Americans with type 2 diabetes mellitus.

Avilés-Santa L, Salinas K, Adams-Huet B, Raskin P.

J Investig Med. 2006 Jan;54(1):20-31.

PMID: 16409887 [PubMed - indexed for MEDLINE]

19:

Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.

Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.

Nutr Metab Cardiovasc Dis. 2006 Mar;16(2):137-47. Epub 2005 Oct 20.

PMID: 16487914 [PubMed - indexed for MEDLINE]

20:

Comparative study on the efficacy of pioglitazone in Caucasian and Maori-Polynesian patients with poorly controlled type 2 diabetes.

Shand B, Scott R, Connolly S, Clarke R, Baker J, Elder P, Frampton C, Yeo J.

Diabetes Obes Metab. 2007 Jul;9(4):540-7.

PMID: 17587396 [PubMed - indexed for MEDLINE]

Recent Activity